We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+28.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
-$202M
Cap. Flow
-$355M
Cap. Flow %
-35.04%
Top 10 Hldgs %
17.77%
Holding
972
New
385
Increased
62
Reduced
71
Closed
428

Top Buys

Rank Stock Value
1
AHCO icon
AdaptHealth
AHCO
+$14.9M
2
CLGX
Corelogic, Inc.
CLGX
+$14.2M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$13.5M
4
GDRX icon
GoodRx Holdings
GDRX
+$13.3M
5
SHC icon
Sotera Health
SHC
+$13.1M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$32.8M
2
CZR icon
Caesars Entertainment
CZR
+$22.3M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$20.7M
4
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
+$15.2M
5
BHP icon
BHP
BHP
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 32.37%
2 Technology 10.24%
3 Industrials 10.18%
4 Financials 8.13%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
201
Amgen
AMGN
$203B
$1.25M 0.12%
5,452
+2,490
+84% +$574K
LIN icon
202
CALL
Linde
LIN
$237B
$1.24M 0.12%
+4,700
New +$1.15M
TVTX icon
203
Travere Therapeutics
TVTX
$5.33B
$1.24M 0.12%
+44,906
New +$1.05M
DNMR
204
DELISTED
Danimer Scientific, Inc.
DNMR
$1.23M 0.12%
1,250
– –
HD icon
205
Home Depot
HD
$332B
$1.22M 0.12%
+4,576
New +$1.26M
LULU icon
206
lululemon athletica
LULU
$13B
$1.2M 0.12%
+3,418
New +$1.19M
FOLD
207
DELISTED
Amicus Therapeutics
FOLD
$1.2M 0.12%
+51,704
New +$1.06M
ABT icon
208
PUT
Abbott
ABT
$180B
$1.19M 0.12%
10,900
+1,400
+15% +$152K
OBIO icon
209
Orchestra BioMed
OBIO
$224M
$1.19M 0.12%
91,715
-33,285
-27% -$379K
ALSK
210
DELISTED
Alaska Communications Systems
ALSK
$1.19M 0.12%
+321,115
New +$915K
GILD icon
211
Gilead Sciences
GILD
$161B
$1.18M 0.12%
20,269
+4,756
+31% +$287K
CLOV icon
212
Clover Health Investments
CLOV
$2.28B
$1.17M 0.12%
70,000
-29,999
-30% -$334K
HTPA.U
213
DELISTED
Highland Transcend Partners I Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
HTPA.U
$1.17M 0.12%
+110,000
New +$1.15M
HAACU
214
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
$1.14M 0.11%
+100,000
New +$1.08M
ACM icon
215
Aecom
ACM
$9.07B
$1.12M 0.11%
+22,500
New +$1.08M
RMGBU
216
DELISTED
RMG Acquisition Corp. II Unit
RMGBU
$1.11M 0.11%
+100,000
New +$1.07M
CLDX icon
217
Celldex Therapeutics
CLDX
$2.77B
$1.11M 0.11%
+62,176
New +$1.12M
FMTX
218
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$1.11M 0.11%
+29,700
New +$1.29M
KDMN
219
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.11M 0.11%
+258,173
New +$1.02M
SPFR.U
220
DELISTED
JAWS Spitfire Acquisition Corp Units, each consisting of one Class A ordinary share, and one-fourth
SPFR.U
$1.1M 0.11%
+100,000
New +$1.08M
TIF
221
DELISTED
Tiffany & Co.
TIF
$1.1M 0.11%
8,381
-24,119
-74% -$3.09M
REPL icon
222
Replimune Group
REPL
$814M
$1.1M 0.11%
+26,000
New +$1.08M
CB icon
223
Chubb
CB
$140B
$1.09M 0.11%
7,113
-2,289
-24% -$321K
TCRR
224
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1.09M 0.11%
+35,284
New +$892K
NAUT icon
225
Nautilus Biotechnolgy
NAUT
$215M
$1.09M 0.11%
100,000
+28,100
+39% +$296K
7 8
9
10 11

Similar funds

AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $5.16B AUM 9.8% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Maven Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Maven Securities held 972 positions worth $1.01B, down 17% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Maven Securities withdrew a net $355M in Q4 2020, closing 428 positions and reducing 71 holdings. Its most notable exit was Immunomedics Inc, an estimated $32.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Maven Securities opened a new position in Corelogic, Inc. worth $14.7M.

  • Maven Securities's largest Q4 2020 buy was Corelogic, Inc.: 189,483 shares worth $14.7M.
  • Maven Securities added most to AdaptHealth in Q4 2020, an estimated $14.9M increase.
  • Maven Securities's biggest Q4 2020 reduction was Triterras, Inc. Class A Ordinary Shares, cutting an estimated $15.2M.
  • Maven Securities fully exited Immunomedics Inc in Q4 2020, selling an estimated $32.8M.
  • Maven Securities's ten largest holdings make up 18% of its $1.01B portfolio in Q4 2020.
  • Maven Securities opened 385 new positions and closed 428 in Q4 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.01B.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.